Bar Ben Baruch

Bar Ben Baruch has a diverse work experience in the field of biotherapeutics and medicinal chemistry. They began their career as an Instructor at the Weizmann Institute of Science in 2012, before transitioning to a PhD Student role at Tel Aviv University in 2013. After completing their PhD, Bar worked as a Research Associate at Micha Fridman's Group for Bio-Organic and Medicinal Chemistry from 2018 to 2019. They then joined FutuRx in 2019 as a Scientist, where they worked until 2021. Currently, Bar is employed at Emendo Biotherapeutics, initially serving as a Scientist and Team Leader from 2021 to 2022, and later transitioning to the position of Director of Pre-Clinical Research in 2022.

Bar Ben Baruch received their Bachelor of Science (BSc) degree in Biology from Tel Aviv University, where they studied from 2010 to 2013. Following this, they pursued a Doctor of Philosophy (PhD) degree, specializing in Cancer Biology, Neurobiology, and Immunology, also at Tel Aviv University, from 2013 to 2019.